Wellgistics Health Raises Convertible Funding, Outlines 2026 Strategy

Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potentialWellgistics Health Inc ( (WGRX) ) just unveiled an announcement. On January 5, 2026, Wellgistics Health, Inc. entered into a private note purchase agreement to issue up to $3.125 million in convertible promissory notes, raising $2.5 million in gross proceeds at a 20% original issue discount, with the notes carrying 0% interest absent default, a six‑month maturity or earlier conversion in a qualified financing, and a conversion floor price set at $0.08 per share to avoid issuing more than 20% of the company’s capitalization. The financing, which is fully guaranteed by a subsidiary and arranged through Dawson James Securities as placement agent in exchange for cash commissions and equity warrants, imposes restrictions on additional indebtedness and new liens while granting investors participation rights in future offerings, effectively shoring up near-term liquidity but limiting the company’s ability to take on new debt as it pursues its growth strategy. In a January 7, 2026 corporate outlook, management outlined a 2026 execution plan centered on integrating EinsteinRx into pharmacy point-of-sale systems, ramping conversion of its existing independent pharmacy customers into the formal Wellgistics Pharmacy Network with a target onboarding rate of up to 500 pharmacies per month by year-end 2026, and expanding manufacturer relationships in large and fast-growing therapeutic areas such as diabetes, GLP-1-related weight loss, cardiometabolic disease and Long COVID. The company also reported that it has begun optimizing the onboarding process with early pharmacy adopters and is assessing required resources to advance its PharmacyChain smart contracts platform, positioning itself to streamline reimbursement, enhance payer transparency and reduce administrative burden and fraud in the healthcare delivery ecosystem. More about Wellgistics Health Inc Wellgistics Health, Inc. (Nasdaq: WGRX) is a U.S. health information technology company that integrates its proprietary EinsteinRx™ pharmacy dispensing optimization AI platform with its patented blockchain-enabled PharmacyChain™ smart contracts platform to streamline the prescription drug dispensing journey. The company connects more than 6,500 independent pharmacies and over 200 manufacturers, providing wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization and cash-pay fulfillment, with a focus on improving access, transparency and trust in the U.S. prescription drug market for independent pharmacies. Average Trading Volume: 14,251,717 Technical Sentiment Signal: Strong Sell Current Market Cap: $37.69M For a thorough assessment of WGRX stock, go to TipRanks’ Stock Analysis page.